证券代码：688386 证券简称：泛亚微透 公告编号：2023-041 江苏泛亚微透科技股份有限公司关于持股 5%以上股东 集中竞价减持计划时间届满未减持公司股份的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 本次减持计划实施前，江苏泛亚微透科技股份有限公司（以下简称"泛亚微 透"或"公司"）股东江苏南方精工股份有限公司（以下简称"南方精工"）持有 公司 5,583,157 股，占公司总股本比例为 7.98%。上述股份来源于泛亚微透首次 公开发行前持有的股份, 且已于 2021 年 10 月 18 日起上市流通。 集中竞价减持计划的实施结果情况 | 股东名称 | 股东身份 | 持股数量（股） | 持股比例 | | 当前持股股份来源 | | --- | --- | --- | --- | --- | --- | | 江苏南方精工股份 | 5%以上非第一大股东 | 5,583,157 | | 7.98% IPO | 前取得：5,583,157 股 | | 有限公司 | | ...

投资者可于 2023 年 09 月 13 日(星期三) 至 09 月 19 日(星期二)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zhengquan@microvent.com.cn 进行提问。公司将在说明会上对投资者普遍关注 的问题进行回答。 证券代码：688386 证券简称：泛亚微透 公告编号：2023-042 江苏泛亚微透科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 09 月 20 日(星期三) 下午 13:00-14:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 三、 参加人员 （三） 会议召开方式：上证路演中心网络互动 江苏泛亚微透科技股份有限公司（以下简称"公司"）已于 2023 年 8 月 29 日发布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解 ...

东方证券承销保荐有限公司 关于江苏泛亚微透科技股份有限公司 公司产品主要应用于汽车、消费电子等领域，近几年，由于地缘政治、国际 贸易战等原因，全球的宏观经济形势仍然存在一定的不确定性。如果宏观经济环 境发生重大不利变化、经济步入下行周期或影响下游终端消费电子、汽车行业的 市场需求因素发生显著变化，则可能对公司经营业绩造成不利影响。 （二）经营风险 2023 年半年度持续督导跟踪报告 东方证券承销保荐有限公司（以下简称"东方投行""保荐机构"）作为江苏 泛亚微透科技股份有限公司（以下简称"泛亚微透""公司"）首次公开发行股票 并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证 券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第 11 号 ——持续督导》等有关法律法规和规范性文件的要求，负责泛亚微透上市后的持 续督导工作，并本出具持续督导跟踪报告。 一、持续督导工作情况 | 序 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 号 | | | | 1 | 建立健全并有效执行持续督导工作制度， | 保荐机构已制定持续督导计划，并依 | | | 并针对 ...

Financial Performance - The company's operating revenue for the first half of 2023 was RMB 175,915,085.08, representing a 20.27% increase compared to RMB 146,264,226.11 in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2023 was RMB 40,024,752.78, a 51.44% increase from RMB 26,429,385.92 year-on-year[19]. - The basic earnings per share for the first half of 2023 was RMB 0.57, up 50.00% from RMB 0.38 in the same period last year[20]. - The company reported a non-recurring profit of 12,697,611.19, after accounting for tax effects and minority interests[24]. - The company achieved operating revenue of 175.92 million yuan, a year-on-year increase of 20.27%[74]. - The net profit attributable to shareholders reached 40.02 million yuan, reflecting a year-on-year growth of 51.44%[74]. Cash Flow and Assets - The net cash flow from operating activities decreased by 59.92% to RMB 22,188,844.73, down from RMB 55,358,250.49 in the previous year, primarily due to increased material procurement and tax payments[21]. - The company's total assets decreased by 1.78% to RMB 875,877,476.07 compared to RMB 891,727,828.65 at the end of the previous year[20]. - The company's cash and cash equivalents decreased to RMB 54,006,145.52 from RMB 106,229,233.62, a decline of about 49.1%[168]. - The company's total liabilities decreased to RMB 219,860,117.97 from RMB 244,484,838.11, a decline of approximately 10.0%[170]. - The company's equity increased to RMB 656,017,358.10 from RMB 647,242,990.54, representing a growth of about 1.2%[170]. Research and Development - Research and development expenses accounted for 5.87% of operating revenue, an increase of 0.59 percentage points from the previous year[20]. - The company achieved a total R&D expenditure of ¥10,334,903.95, representing a 33.73% increase compared to ¥7,728,290.53 in the same period last year[52]. - The number of R&D personnel increased to 72, representing 20.06% of the total workforce, compared to 56 personnel and 16.57% in the same period last year[66]. - The average salary of R&D personnel decreased to 7.13 million RMB from 8.22 million RMB in the previous year[66]. - The company has established a complete technology system for ePTFE membranes and composite materials, covering production, modification, and application processes[67]. Product Development and Innovation - The company specializes in the research, production, and sales of ePTFE membranes and SiO2 aerogels, targeting high-performance composite materials[28]. - The CMD solution has been adopted by 31 automotive lighting manufacturers and 16 OEMs, significantly reducing manufacturing processes and costs associated with fog solutions[39]. - The company has developed high-performance desiccants with a moisture absorption capacity of up to 200% of their own weight, which can be reversibly dried and used for extended periods[46]. - The company has developed a novel silica aerogel material for sound insulation and thermal insulation, achieving a sample verification with a major engineering project, enhancing comfort and health for personnel[59]. - The company has initiated multiple new R&D projects to develop new products and expand market space, leading to increased material consumption and testing costs[54]. Market and Strategic Focus - The company is focusing on expanding into new niche markets, particularly in the automotive sector, to meet the demands of the "new four modernizations"[76]. - The company aims to enhance its product offerings in the aviation sector with new sealing materials, which are expected to improve safety and reliability[57]. - The company is actively pursuing high-performance membrane materials for applications in cables and cable components, aligning with its development strategy of product diversification and market niche[106]. - The company has outlined a strategic plan for mergers and acquisitions, aiming to complete at least two acquisitions by the end of the fiscal year[130]. - The company is focusing on market expansion, targeting a 15% increase in market share over the next fiscal year[130]. Risk Management - The company has outlined various risks and countermeasures in its report, emphasizing the importance of risk management in its operations[4]. - The company is facing risks related to macroeconomic uncertainties and potential goodwill impairment from previous acquisitions[81][82]. - The company faces risks related to high customer concentration in the automotive industry, which could impact demand if customer operations decline[86]. - The company has implemented policies to prevent core technology leakage and personnel loss, which are critical for maintaining competitive advantage[85]. Environmental Responsibility - The company has established an emergency response plan for environmental incidents, which has been filed with the relevant environmental authority[119]. - The company conducts quarterly third-party monitoring of its wastewater, waste gas, and noise emissions, ensuring compliance with environmental standards[120]. - The company has implemented measures to reduce VOCs and particulate matter emissions through upgrades to its production facilities[122]. - The company promotes waste classification and recycling among employees, contributing to environmental awareness[124]. - The company is engaged in research and development of new products that contribute to carbon reduction and practices green office initiatives[126]. Shareholder and Governance - The company has committed to maintaining transparency in its financial reporting and adhering to regulatory requirements[133]. - The company has committed to repurchase shares if there are significant misstatements or omissions in the prospectus, with the commitment period starting from March 26, 2020, and lasting indefinitely[128]. - The company will not transfer or delegate the management of its shares within 36 months from the date of stock issuance[136]. - The company has not reported any changes in controlling shareholders or actual controllers during the reporting period[164]. - The company has not reported any significant changes in shareholding or shareholder structure during the reporting period[157].

证券代码：688386 证券简称：泛亚微透 公告编号：2023-039 江苏泛亚微透科技股份有限公司 第三届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江苏泛亚微透科技股份有限公司（以下简称"公司"）第三届监事会第十三 次会议通知于2023年 8月18日以直接送达、微信等方式发出，并通过电话进行确 认，会议于2023年8月28日在公司会议室以现场会议方式召开。会议应出席监事3 名，实际出席监事3名。会议由监事会主席张斌先生主持。本次会议的召集、召开和表 决程序符合《公司法》、《公司章程》的规定，合法有效。 经与会监事逐项认真审议，会议以记名投票表决的方式通过了如下议案： 2、审议通过了《关于2023年半年度募集资金存放与实际使用情况的专项 报告的议案》 监事会认为：公司编制的《2023 年半年度募集资金存放与实际使用情况的 专项报告》符合相关法律法规的要求，真实地反映了报告期内募集资金的存放 与实际使用情况。不存在变相改变募集资金投向和损害公司及全体股东利益的 情形。 表决结果：同意3票； ...

证券代码：688386 证券简称：泛亚微透 公告编号：2023-040 江苏泛亚微透科技股份有限公司 关于2023年半年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真性、准确性和完整性承担个别及连带责任。 一、募集资金基本情况 （一）募集资金金额和资金到账时间 根据中国证券监督管理委员会于 2020 年 9 月 1 日出具的《关于同意江苏泛 亚微透科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2020〕2015 号）核准，江苏泛亚微透科技股份有限公司（以下简称"公司"）获准首次向社 会公众公开发行人民币普通股 17,500,000 股，每股面值为人民币 1.00 元，发 行价格为每股人民币 16.28 元/股，募集资金总额为人民币 284,900,000 元，扣 除发行费用人民币 47,369,737.04 元后，公司本次募集资金净额为人民币 237,530,262.96 元。截至 2020 年 10 月 13 日，上述募集资金已经全部到位。 以上募集资金的到位情况已由天健会计师事务所（特殊普通合伙）审验并于 ...

江苏泛亚微透科技股份有限公司独立董事 关于第三届董事会第十三次会议相关事宜的独立意见 江苏泛亚微透科技股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召开公司第三届董事会第十三次会议。根据《中华人民共和国公司法》、公司 内部规定并参照上市公司相关制度等相关规定，我们作为公司的独立董事，在审 阅有关文件资料后，对公司第三届董事会第十三次会议审议的相关事项，基于独 立判断的立场，发表意见如下： 一、关于2023年半年度募集资金存放与使用情况的独立意见 公司独立董事审阅了《关于2023年半年度募集资金存放与实际使用情况的 专项报告》，并发表了以下独立意见： 经核查，公司2023年半年度募集资金的存放和使用符合中国证监会、上海 证券交易所关于上市公司募集资金存放和使用的相关监管要求和管理办法，不存 在募集资金存放和使用违规的情形。公司所披露的募集资金存放和使用情况信息 与实际情况一致，如实履行了信息披露义务。 （以下无正文） （本页无正文，为《江苏泛亚微透科技股份有限公司独立董事关于第三届董事会 第十三次会议相关事宜的独立意见》之签字页） 独立董事签字： 许明强： 陈 强： 钱技平： 2023 年 ...

证券代码：688386 证券简称：泛亚微透 公告编号：2023-038 江苏泛亚微透科技股份有限公司 第三届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 江苏泛亚微透科技股份有限公司（以下简称"公司"或"泛亚微透"）第 三届董事会第十三次会议（以下简称"会议"）于2023年8月18日以直接送达、 微信等方式发出通知，并通过电话进行确认，会议于2023年8月28日以现场加视 频会议方式召开。会议应出席董事9名，实际出席董事9名，会议由董事长张云 先生主持，本次会议的召集、召开和表决程序符合有关法律、法规和《公司章 程》的规定，会议形成的决议合法有效。 经与会董事认真审议，以记名投票表决方式审议通过了如下议案： 董事会 2023年8月29日 1 具体内容详见公司同日刊登于上海证券交易所网站 (www.sse.com.cn) 的 《泛亚微透2023年半年度报告》及《泛亚微透2023年半年度报告摘要》。 2、审议通过了《关于2023年半年度募集资金存放与实际使用情况的专项 报告的议案》 表决结果：9 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥77,414,260.29, representing a year-on-year increase of 2.91%[4] - The net profit attributable to shareholders decreased by 35.90% to ¥11,539,385.39 compared to the same period last year[4] - Total operating revenue for Q1 2023 was CNY 77,414,260.29, a 2.6% increase from CNY 75,226,296.26 in Q1 2022[15] - Net profit for Q1 2023 was CNY 13,324,376.81, a decrease of 26.5% compared to CNY 18,090,454.47 in Q1 2022[16] - The company reported a total comprehensive income of CNY 13,324,376.81 for Q1 2023, a decrease from CNY 18,090,454.47 in the previous year[16] Cash Flow - The net cash flow from operating activities fell by 74.37% to ¥7,058,625.59, primarily due to tax payments related to the previous year[6] - Cash flow from operating activities generated a net amount of CNY 7,058,625.59, down 74.5% from CNY 27,543,050.89 in the previous year[20] - Cash flow from investing activities showed a net outflow of CNY 20,300,374.15, compared to a net outflow of CNY 158,388,711.31 in Q1 2022[21] - Cash flow from financing activities resulted in a net outflow of CNY 5,743,266.67, compared to a net outflow of CNY 1,405,375.00 in the same period last year[21] - The ending balance of cash and cash equivalents was CNY 87,103,366.54, compared to CNY 40,682,977.38 at the end of Q1 2022[21] Research and Development - Research and development expenses totaled ¥5,497,392.77, an increase of 46.77% year-on-year, accounting for 7.10% of operating revenue[4][5] - Research and development expenses rose to CNY 5,497,392.77, representing a 46.8% increase from CNY 3,745,592.45 in Q1 2022[15] Assets and Liabilities - Total assets at the end of the reporting period were ¥901,956,859.56, reflecting a 1.15% increase from the end of the previous year[5] - The company's current assets totaled RMB 386,854,055.46, compared to RMB 379,454,266.08 at the end of 2022, indicating an increase of about 1.1%[12] - The total liabilities decreased to RMB 241,389,492.21 from RMB 244,484,838.11, showing a decrease of approximately 1.3%[14] - The company's equity attributable to shareholders increased to RMB 629,082,669.86 from RMB 617,543,284.47, reflecting a growth of about 1.8%[14] - The total equity increased to RMB 660,567,367.35 from RMB 647,242,990.54, marking an increase of about 2.1%[14] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 3,877[9] - The top shareholder, Zhang Yun, holds 27.87% of the shares, totaling 19,511,467 shares[9] Operational Strategy - The company does not anticipate any significant changes in its operational strategy for the upcoming quarters[6]

Financial Performance - The company's operating revenue for 2022 was CNY 364,464,300.36, representing a 15.11% increase compared to CNY 316,615,240.65 in 2021[21]. - The net profit attributable to shareholders for 2022 was CNY 31,344,909.48, a decrease of 52.79% from CNY 66,398,200.58 in 2021[22]. - The net cash flow from operating activities for 2022 was CNY 79,136,698.62, down 2.87% from CNY 81,470,932.14 in 2021[22]. - The basic earnings per share for 2022 was CNY 0.45, a decline of 52.63% compared to CNY 0.95 in 2021[23]. - The company recorded a goodwill impairment of CNY 45,727,700 due to the underperformance of a subsidiary acquired in 2021, impacting various financial metrics[23]. - The company experienced a significant decline in net profit in the fourth quarter of 2022, reporting a loss of CNY 11,429,173.58 attributable to shareholders[25]. - The net profit attributable to shareholders decreased by 52.79% year-on-year, primarily due to goodwill impairment from the acquisition of a subsidiary, while excluding this factor, the net profit increased by 16.08% to 77.07 million RMB[34]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 5.00 RMB per 10 shares, totaling 35 million RMB, which accounts for 111.66% of the net profit attributable to shareholders in 2022[5]. - The company has not proposed any stock bonus or capital reserve transfer to increase share capital for the year 2022[5]. Governance and Compliance - The company has confirmed that all board members attended the board meeting, ensuring the integrity of the report[7]. - The company has received a standard unqualified audit report from Tianjian Accounting Firm[7]. - The company has not violated any decision-making procedures regarding external guarantees[8]. - The company has not experienced any changes in its governance structure that would affect the report's accuracy[8]. - The company has established a solid governance structure, ensuring compliance with relevant laws and regulations, and maintaining operational independence[178]. - The company has established a board of directors with three independent directors who provide independent opinions on decision-making[180]. - The supervisory board consists of three members, including one chairman and one employee representative, complying with legal requirements[180]. - The company strictly adheres to information disclosure regulations, ensuring timely and accurate communication with shareholders[180]. Research and Development - The company invested 17.18 million RMB in R&D, accounting for 4.71% of operating revenue, and added 16 new patents in 2022[35]. - The company has a strong focus on R&D, continuously improving ePTFE membrane technology to expand its applications across various industries[68]. - The company has established a comprehensive patent system, making it difficult for competitors to replicate its products due to high technical and legal risks[105]. - The company is actively collaborating with universities to enhance its innovation capabilities in new materials and technologies[105]. - The company has reported a significant increase in R&D efforts, with 1,200 samples developed for various applications, including automotive and communication sectors[110]. - The company is committed to increasing its R&D capabilities and converting innovations into patented technologies to strengthen its competitive edge[172]. Market and Product Development - The company is actively involved in the hydrogen energy industry through the establishment of Jiangsu Yuan Hydrogen New Energy Technology Co., focusing on key materials for proton exchange membranes[36]. - The company’s core products include ePTFE membranes and SiO2 aerogels, which are applied in various industries including automotive and consumer electronics[37]. - The company plans to expand its product applications into medical, communication, and military sectors, leveraging its technological advancements[171]. - The company aims to enhance its market position by exploring niche markets and increasing the number of targeted segments[171]. - The company is focusing on expanding its market presence and enhancing its product offerings through strategic leadership[187]. Operational Risks and Challenges - The company has faced various operational risks, which are detailed in the management discussion and analysis section of the report[4]. - The company faced risks related to high customer concentration, primarily in the automotive industry[129]. - The company experienced a decrease in cash flow from financing activities by 108.72%, attributed to no dividends and no new bank loans[142]. Employee and Leadership Structure - The company has a diverse leadership team with extensive experience across various industries, including finance, manufacturing, and technology[187]. - The total pre-tax compensation for all directors and supervisors amounted to 4.86 million yuan[186]. - The company has experienced a change in personnel, with the resignation of the technical director, Song Haimin[193]. - The company has established a performance evaluation process to determine the performance-based salary for its management[192]. Strategic Initiatives - The company has implemented a restricted stock incentive plan in 2022 to motivate and retain key technical and business personnel[174]. - The company has proposed to establish a joint venture for the construction of a hydrogen fuel cell proton exchange membrane project[184]. - The company plans to maintain high R&D investment levels to support new product development despite inherent risks[125].